Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials.
about
Amiodarone versus other pharmacological interventions for prevention of sudden cardiac deathProphylactic lidocaine for myocardial infarctionBlood pressure lowering efficacy of nonselective beta-blockers for primary hypertensionProphylactic lidocaine for myocardial infarctionRandomisation to protect against selection bias in healthcare trialsRandomisation to protect against selection bias in healthcare trialsCurrent Controlled Trials: an opportunity to help improve the quality of clinical researchDebate: Do all patients with heart failure require implantable defibrillators to prevent sudden death?Outcomes research in the development and evaluation of practice guidelinesDrug therapy for prevention of recurrent myocardial infarctionEvidence for an age and gender bias in the secondary prevention of ischaemic heart disease in primary careCombination therapy improves survival after acute myocardial infarction in the elderly with chronic kidney diseaseManagement of the older person with atrial fibrillation.Atrial Fibrillation: The New Epidemic of the Ageing WorldManagement of the older person with ventricular arrhythmias.Surgery for postinfarction ventricular tachycardia in the pre-implantable cardioverter defibrillator era: early and long term outcomes in 100 consecutive patients.Management of acute myocardial infarction in general medical wards in Sri Lanka.Regular review: treatment possibilities for unstable angina.Myocardial infarction (ST-elevation).Reporting of gender-related information in clinical trials of drug therapy for myocardial infarctionDrugs used in secondary prevention after myocardial infarction: case presentation.beta-Blocker use following myocardial infarction: low prevalence of evidence-based dosing.Modern adjunctive pharmacotherapy of myocardial infarction.Heart rate as a cardiovascular risk factor: do women differ from men?New insights into the mechanisms and management of atrial fibrillationClinical trials of antiarrhythmic drugs in postmyocardial infarction and congestive heart failure patients.Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries.Effect of Beta-Blocker Dose on Survival After Acute Myocardial Infarction.Sudden cardiac death: mechanisms, therapies and challenges.Premature cardiac contractions and risk of incident ischemic stroke.Beta-Blocker Therapy Early After Myocardial Infarction: A Comparison Between Medication at Hospital Discharge and Subsequent Pharmacy-Dispensed MedicationAtrial fibrillation and heart failure in the elderly.The prognostic significance of frequency and morphology of premature ventricular complexes during ambulatory holter monitoring.Angina pectoris: current therapy and future treatment options.Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force.Current treatment of hypertension in patients with coronary artery disease recommended by different guidelines.Management of older persons after myocardial infarction.A multicenter observational study of the effectiveness of antiarrhythmic agents in ventricular arrhythmias: A propensity-score adjusted analysis.Treatment of ventricular arrhythmias in older adults.Cardiology--II: Treatment of heart failure and atrial fibrillation and arrhythmias.
P2860
Q24187185-80A0E72C-79D6-421F-9C78-B2D782A845E8Q24187816-D19191E9-9B88-4A46-9026-B52D6614D198Q24200205-1D10E54C-2BF7-484E-A5DA-DBF650159E2EQ24235110-A19CAF57-1C4C-4F7A-B673-EFD257696473Q24235283-DD18EE4A-569B-4E88-8293-31CB97ED36EEQ24245576-94139391-0814-46A6-AD5F-2A7B629DF5E8Q24792307-C58D1720-3834-4A62-9723-C3C25CC0431DQ24792670-CDA20107-B9CF-48D7-AAC9-16B8875E60FBQ24806205-A5DFFE44-7892-4095-BCBE-52FDE26AA9D7Q28165520-90011DA7-E1D2-4424-8D55-7E477FF475FDQ28196488-6274CDD8-4DDB-4F27-A5FD-AAFCBEE2FB51Q28211805-91B77D76-B612-4567-9DFB-CAF98ABC11DDQ33144789-DA2B0616-0D90-48F8-9A71-8134AEE0F24EQ33168630-34E45ED3-E0D0-44F5-9E6B-E991935C8582Q33686613-0AF7D0B9-29E0-4858-802D-BA631E390F11Q33688992-331ECFB5-8A0B-4ED3-ACE5-3645D78D7BE1Q33776602-8DA25DCF-EBF9-4EE3-9FFC-A23C990269FDQ33802938-3BE2E2C4-5375-44B3-87CD-19156457084EQ33866536-8856818B-ED62-4D36-8E23-8FB873706E3EQ34029387-D6A70E76-3F4E-42A1-9185-1DDF9C88CE9DQ34078583-96979AA9-35F9-418A-ADB4-6C0678170CB9Q34125706-9F98D27D-38A5-4652-9BE2-D03B2F558FFBQ34182163-E71EF611-767F-417A-905D-E279F8CDB6EDQ34281167-ACC38A71-A76E-41CE-B060-534B124C99ABQ34289414-5CA5F163-ED90-484C-A309-9735E247225DQ34308130-C2FF7772-D0ED-4BB9-9A59-BCA46CAC4826Q35580407-1A90C3F6-670B-4B2B-9D74-A09AB2D9DB21Q36094414-7E87A600-0048-4002-BD1B-0F78DDC0B3CDQ36304357-D662018B-CFBE-45F7-B779-705834CEF814Q36522603-4D6AC072-85FF-4EEF-A40F-BD6A1FDEFC9EQ37297906-67269B23-0AAF-40ED-945F-E4F2E237AD14Q37952604-A6333F74-9B46-4758-85C0-4597246240DDQ38093177-94196A3E-A7E9-4F38-905E-5AF15EF74D89Q38177869-1FCA81FD-5F59-43E7-8E18-FDF1F30A9084Q38244795-5AF728EB-5CA3-4C9C-8F0D-2633F6766B72Q38587542-DF933D9E-1004-4642-88D8-75BD3F2475E6Q39443735-E6B701A1-B8E2-403B-92EA-B64D01869B33Q39646654-70378314-8232-46DF-968B-6523ED995CB6Q40401401-3F159B6A-CB63-4FDF-8217-C2C8B9CF8103Q40568336-08938E27-B3C6-4E0F-A178-4063D6C57156
P2860
Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Effects of prophylactic antiar ...... randomized controlled trials.
@en
type
label
Effects of prophylactic antiar ...... randomized controlled trials.
@en
prefLabel
Effects of prophylactic antiar ...... randomized controlled trials.
@en
P2093
P1476
Effects of prophylactic antiar ...... randomized controlled trials.
@en
P2093
P304
P356
10.1001/JAMA.1993.03510130095038
P407
P577
1993-10-01T00:00:00Z